Rapid Risk Assessment: Zika virus disease epidemic: potential association with microcephaly and Guillain-Barré syndrome (first update)
This updated rapid risk assessment evaluates the risks associated with the evolving Zika virus epidemic currently affecting some countries in the Americas, including the risk for travellers to the affected areas and populations in the affected EU outermost regions.
Communicable disease threats report, 24-30 January 2016, week 4
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 January 2016 and includes updates on Zika virus, Ebola virus disease and MERS.
No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in EuropeArchived
Due to an association that was observed in the United States between a swine-flu based human influenza vaccine developed in 1976 and the disease acute polyneuropathy Guillain-Barré syndrome (GBS) (1,2), GBS was one of the adverse events that was monitored in Europe and North America (3) following the 2009 influenza pandemic vaccination campaigns.
Communicable disease threats report, 13-19 May 2018, Week 20
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 May 2018 and includes updates on E.coli, seasonal influenza, dengue, hepatitis A, measles, rubella, yellow fever and Ebola.
Monitoring and assessing vaccine safety: A European perspective
Lopalco, P. L., Johansen, K., Ciancio, B., De Carvalho Gomes, H., Kramarz, P., Giesecke, J.
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: Multinational case-control study in Europe
Dieleman, J., Romio, S., Johansen, K., Weibel, D., Bonhoeffer, J., Sturkenboom, M.